Trial intelligence / Profile preview

Influence of sevoflurane and propofol on maximum muscular strength, speed of contraction and relaxation in humans

2022-003737-19Phase 2Completed

Sponsor
CHU Brugmann
Start
Nov 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of sevoflurane and propofol (2 arms), sponsored by CHU Brugmann. Primary endpoints: Maximum force of adductor pollicis, Maximum speed of contraction of adductor pollicis and 1 more. Started Nov 2022; status: completed.

02

Drugs

sevofluranepropofol

Beyond the preview

Go deeper on 2022-003737-19.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2022-003737-19.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call